Organigram (TSE:OGI) Given New C$3.15 Price Target at Canaccord Genuity Group

Organigram (TSE:OGI) had its target price trimmed by Canaccord Genuity Group from C$3.60 to C$3.15 in a research report report published on Monday morning,BayStreet.CA reports. The firm currently has a speculative buy rating on the stock.

Organigram Stock Performance

Shares of TSE:OGI opened at C$2.23 on Monday. The firm has a market capitalization of C$242.11 million, a PE ratio of -0.89, a P/E/G ratio of 0.42 and a beta of 1.13. The company has a debt-to-equity ratio of 1.13, a current ratio of 6.95 and a quick ratio of 2.62. The business has a 50-day moving average of C$2.29 and a two-hundred day moving average of C$2.32. Organigram has a 12 month low of C$1.61 and a 12 month high of C$3.95.

Insider Activity at Organigram

In related news, Senior Officer Paolo De Luca sold 13,835 shares of the stock in a transaction dated Wednesday, September 11th. The stock was sold at an average price of C$2.54, for a total value of C$35,140.90. Following the completion of the transaction, the insider now owns 625 shares of the company’s stock, valued at approximately C$1,587.50. This represents a 95.68 % decrease in their ownership of the stock. 31.32% of the stock is currently owned by company insiders.

About Organigram

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O’ Buds, Monjour, Trailblazer, SHRED’ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.